Clinical Trials Directory

Trials / Completed

CompletedNCT02971553

PEEP Resuscitation Trial

A Randomised Controlled Trial on Positive End-expiratory Pressure (PEEP) During Resuscitation of Non-breathing Neonates

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
330 (actual)
Sponsor
Helse Stavanger HF · Other Government
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Each year, almost 3 million newborn babies die within their first month of life, often as a consequence of labour complications. Approximately 5% of newborns will not start breathing at birth and need immediate help. The optimal ventilation strategy with liquid-filled lungs has not been determined. Animal studies suggest that assisted ventilation with positive end expiratory pressure (PEEP) improves the aeration of liquid-filled lungs leading to more rapid recovery. However, no large human clinical studies have investigated the clinical responses to assisted ventilation with PEEP in asphyxiated newborns.

Detailed description

Laerdal Global Health has developed a PEEP valve which has been tested and shown to provide reliable end-expiratory pressures in a manikin model, even with a high mask leak. Whether this PEEP valve provides reliable PEEP in vivo and whether this translates to clinical beneficial outcomes remains to be proven. The aim is to study whether lung aeration can be improved by adding a device for positive end expiratory pressure (PEEP) to better distend the airways in neonates more than 28 weeks gestation.

Conditions

Interventions

TypeNameDescription
DEVICEUpright Resuscitator with PEEP
DEVICEUpright Resuscitator

Timeline

Start date
2016-10-01
Primary completion
2018-05-01
Completion
2018-05-01
First posted
2016-11-23
Last updated
2019-06-12

Locations

1 site across 1 country: Tanzania

Source: ClinicalTrials.gov record NCT02971553. Inclusion in this directory is not an endorsement.